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Blood-brain barrierSeveral studies suggest a link between shifts in gut microbiota and neurological disorders. Recently, we
reported a high prevalence of Helicobacter suis (H. suis) in patients with Parkinson’s disease. Here, we
evaluated the effect of gastric H. suis infection on the brain in mice. One month of infection with H. suis
resulted in increased brain inflammation, reflected in activation of microglia and cognitive decline.
Additionally, we detected choroid plexus inflammation and disruption of the epithelial blood-
cerebrospinal fluid (CSF) barrier upon H. suis infection, while the endothelial blood-brain barrier (BBB)
remained functional. These changes were accompanied by leakage of the gastrointestinal barrier and
low-grade systemic inflammation, suggesting that H. suis-evoked gastrointestinal permeability and sub-
sequent peripheral inflammation induces changes in brain homeostasis via changes in blood-CSF barrier
integrity. In conclusion, this study shows for the first time that H. suis infection induces inflammation in
the brain associated with cognitive decline and that the choroid plexus is a novel player in the stomach-
brain axis.
 2017 Elsevier Inc. All rights reserved.1. Introduction
The healthy human gastrointestinal tract harbours approxi-
mately 100 trillion commensal bacteria (Clemente et al., 2012;
Foster and McVey Neufeld, 2013). An increasing number of recent
studies indicate that shifts in the gastrointestinal microbiome
caused by a broad variety of triggers, including gastrointestinal
infections, might have a significant effect on our health. Indeed,
dysbiosis has been associated with a wide range of human health
problems (Boulange et al., 2016; Clemente et al., 2012; Dinan
and Cryan, 2017b; Ochoa-Reparaz and Kasper, 2014; Walters
et al., 2014; Zhang et al., 2015), including neurological disorders
such as depression, anxiety-like behaviour, autism, Alzheimer’s
disease and Parkinson’s disease (Bercik et al., 2011; Bravo et al.,
2011; Clapp et al., 2017; Dinan and Cryan, 2017a; Fung et al.,2017; Hu et al., 2016; Kelly et al., 2017; Mulak and Bonaz, 2015;
Parracho et al., 2005; Tognini, 2017; Zhang et al., 2015).
The genus Helicobacter is a group of gram-negative, spiral-
shaped bacteria colonizing the gastrointestinal tract of humans
and animals. Helicobacter pylori (H. pylori) is the best-known gastric
human pathogen and is one of the major causes of gastric cancer
(Kusters et al., 2006). Besides H. pylori, other Helicobacter species,
referred to as non-Helicobacter pylori Helicobacter (NHPH) species,
have also been associated with severe human gastric malignancies
(Haesebrouck et al., 2009). The most common NHPH species in
humans is H. suis (Haesebrouck et al., 2009), which naturally
colonizes the stomach of pigs (Liang et al., 2013) and non-human
primates (Bosschem et al., 2017a). Most likely, transmission of
H. suis occurs through direct or indirect contact between animals
and humans. Additionally, H. suis can be present and survive in
minced pork, suggesting that raw or undercooked pork may be a
source of H. suis infection in humans (De Cooman et al., 2013).
Recently, an exceptionally high frequency (27%) of H. suis DNA
was found in gastric biopsies from human patients with
Parkinson’s disease compared to a control group with no clinical
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also detected in a blood sample from a patient with both parkin-
sonism and Alzheimer’s disease (Blaecher et al., 2013). This patient
received triple therapy with tetracycline, clarithromycin and a pro-
ton pump inhibitor to eradicate H. suis. Interestingly, the gastric
and neurological symptoms improved remarkably (Dobbs et al.,
2013). This finding suggests that the inflammatory effects caused
by Helicobacter are not restricted to the stomach.
To prevent disturbance of brain homeostasis due to alterations
in the systemic blood composition, the brain is protected by a ser-
ies of barriers, including the blood–brain barrier (BBB) and the
blood-cerebrospinal fluid (CSF) barrier (De Bock et al., 2014). It
has been suggested that systemic inflammation may contribute
to the impairment of the BBB (Kortekaas et al., 2005; Stolp and
Dziegielewska, 2009) and the blood-CSF barrier (Demeestere
et al., 2015; Marques et al., 2009, 2007; Vandenbroucke et al.,
2012). Furthermore, multiple neurodegenerative disorders, includ-
ing Parkinson’s disease and Alzheimer’s disease, have been associ-
ated with disruption of the BBB (Lee and Pienaar, 2014; Li et al.,
2015; Stolp and Dziegielewska, 2009) and the blood-CSF barrier
(Balusu et al., 2016a; Bergen et al., 2015; Brkic et al., 2015; Gorle
et al., 2016; Pisani et al., 2012; Vandenbroucke, 2016; Vawter
et al., 1996). Because it has been proposed that Helicobacter infec-
tions cause systemic inflammation (Alvarez-Arellano and
Maldonado-Bernal, 2014; Blaecher et al., 2013), gastric infection
with H. suis could influence the integrity of the brain barriers and
thereby contribute to the pathophysiology of neurodegenerative
disorders.
In this study, we investigated the effect of gastric H. suis infec-
tion on brain homeostasis. Our results show that H. suis induces
inflammation not only in the stomach, but also in the brain. We
identified a novel role for the choroid plexus in the communication
between the gastrointestinal tract and the brain: leakage of the
gastrointestinal barrier induces low-grade systemic inflammation
and subsequent loss of the blood-CSF barrier integrity, increased
brain inflammation and cognitive decline.2. Materials and methods
2.1. Mice
For the Helicobacter infection experiments, female C57BL/
6JOlaHsd mice were purchased from Harlan (Harlan Laboratories,
The Netherlands). The animals were housed in filtertop cages in
groups of 5–10 mice/cage with free access to food and water and
with a 12-h light/12-h dark cycle in a conventional animal house.
All experiments were approved by the ethical committee of the
Faculty of Veterinary Medicine of Ghent University.2.2. Cultivation of H. suis bacteria
H. suis bacteria (strain HS1) were grown biphasically on 1.5%
Brucella agar (Immunosource, Belgium), supplemented with 1 ml
skirrow (Oxoid, United Kingdom), 3 ml vitox (Oxoid, United King-
dom), 5 mg/ml amphotericin B (Sigma-Aldrich, Germany), 0.05%
HCl (Sigma-Aldrich, Germany) and 20% inactivated fetal bovine
serum (Perbio, Thermo Scientific Hyclone, United Kingdom) with
on top Brucella broth (Immunosource, Belgium), supplemented
with 0.05% HCl (Sigma-Aldrich, Germany) (Baele et al., 2008). The
plates were incubated at 37 C under micro-aerobic conditions
(10% CO2, 5% O2 and 85% N2). Using a counting chamber (Neu-
bauwer Improved Assistant) the bacteria were counted and diluted
to 108 viable H. suis bacteria/ml.2.3. In vivo infection procedure
At the age of 6 weeks, animals were anaesthetized with 2.5%
isoflurane and intragastrically inoculated with either 300 ml of a
stock solution containing 108 viable H. suis bacteria/ml or with
300 ml of the growth medium of the bacteria (control group). One
month after infection, mice were euthanized for further analysis
by the administration of an overdose of ketamine/xylazine fol-
lowed by decapitation.
2.4. Tissue collection
For RNA and protein analysis, mice were transcardially perfused
with D-PBS/heparin (0.2% heparin) supplemented with 0.5% bro-
mophenol blue. The stomach (including a small part of the duode-
num) was collected and cut open via the curvatura major. After
rinsing with sterile Hank’s Buffered Salt Solution (Gibco by Thermo
Fisher Scientific, USA), samples from the antrum and the corpus of
the stomach and duodenum were collected and stored in RNAlater
(Qiagen) at 70 C or snap frozen in liquid nitrogen for RNA and
protein extraction, respectively. Brain tissue was dissected out.
The choroid plexus from all four ventricles was collected and snap
frozen in liquid nitrogen, while hippocampus samples were stored
in RNAlater (Qiagen) for RNA analysis or snap frozen in liquid nitro-
gen for DNA analysis.
For immunohistochemical analyses, mice were transcardially
perfused with 4% paraformaldehyde (PFA). Brain tissue and sam-
ples from the antrum and corpus of the stomach and duodenum
were collected. The brain was divided into the left and right hemi-
sphere. The right hemisphere was successively fixated in 4% PFA
and embedded in paraffin for paraffin sections. In parallel, the left
hemisphere was embedded in cryoprotectant (Thermo ScientificTM),
underwent rapid freezing on dry ice and was stored at 70 C. The
stomach and duodenum samples were either stored overnight in
20% sucrose, embedded in cryoprotectant (Thermo ScientificTM),
underwent rapid freezing on dry ice and were stored at 70 C
or were fixated overnight in a solution of 3.7% formaldehyde
(Chem-lab) and subsequently embedded in paraffin (Labo-nord,
VWR).
2.5. DNA extraction and quantification of colonizing H. suis bacteria in
the stomach, duodenum and hippocampus
Stomach and duodenum samples stored in RNAlater were
homogenized using the MagNAlyser (Roche diagnostics) and RNA
and DNA were separated as described before (Joosten et al.,
2013). DNA of the hippocampus was extracted with the Isolate II
Genomic DNA kit (Bioline) according to the manufacturer’s instruc-
tions. The number of colonizing H. suis bacteria per mg tissue was
determined in the obtained DNA samples using Real-Time (RT)-
quantitative (q) Polymerase Chain Reaction (PCR). RT-qPCR detec-
tion of H. suis DNA was performed using the ureA-based primers
(Table 1) (Blaecher et al., 2013) and the standard was generated
as described before (O’Rourke et al., 2004). Standard and samples
of stomach were run in duplicate on a CFX384TM RT-qPCR System
with a C1000 Thermal Cycler (Bio-Rad) according to the manufac-
turer’s instructions. RT-qPCR for hippocampus samples was per-
formed on the Light Cycler 480 system (Roche) using the 2x
Sensimix (Sybr No-Rox kit; Bioline) according to manufacturer’s
instructions.
2.6. RNA extraction and RT-qPCR for gene expression
Using the RNeasy mini kit (Qiagen), total RNA was extracted
from the antrum and the corpus of the stomach, the duodenum,
hippocampus and choroid plexus according to the manufacturer’s
Table 1
Overview of used qRT-PCR primer sequences.
Forward primer sequence Reverse primer sequence
H2afz GGTATCACCCCTCGTCACTT TCAGCGATTTGTGGATGTGT
Hprt (stomach) CAGGCCAGACTTTGTTGGAT TTGCGCTCATCTTAGGCTTT
Ppia AGCATACAGGTCCTGGCATC TTCACCTTCCCAAAGACCAC
Il1b CACCTCACAAGCAGAGCACAAG GCATTAGAAACAGTCCAGCCCATAC
Kc GCTGGGATTCACCTCAAGAA TCTCCGTTACTTGGGGACAC
Mip2 TGCCTGAAGACCCTGCCAAGG GTTAGCCTTGCCTTTGTTCAG
Lix CTCAGTCATAGCCGCAACCGAGC CCGTTCTTTCCACTGCGAGTGC
Ocln CCAGGCAGCGTGTTCCT TTCTAAATAACAGTCACCTGAGGGC
Cldn1 TCTACGAGGGACTGTGGATG TCAGATTCAGCAAGGAGTCG
Cldn5 GCAAGGTGTATGAATCTGTGCT GTCAAGGTAACAAAGAGTGCCA
Muc5ac Purchased from Qiagen (Qt01196006)
Muc5b CAGATCCATCCATCCCATTTCT TATCTGACTACCACTTGTTGATGTGACT
Muc6 TGCTCCCAGAATGAGTACTTCGA CAGAGGTGGAACTGTGAAACTCAGT
Muc13 GCCAGTCCTCCCACCACGGTA CTGGGACCTGTGCTTCCACCG
Tnf ACCCTGGTATGAGCCCATATAC ACACCCATTCCCTTCACAGAG
iNos CAGCTGGGCTGTACAAACCTT CATTGGAAGTGAAGCGTTTCG
Zo1 AGGACACCAAAGCATGTGAG GGCATTCCTGCTGGTTACA
Zo3 ACCCTATGGCCTGGGCTTC CCCGGGTACAACGTGTCC
Hprt (choroid plexus) AGTGTTGGATACAGGCCAGAC CGTGATTCAAATCCCTGAAGT
Rpl CCTGCTGCTCTCAAGGTT TGGTTGTCACTGCCTGGTACTT
Ubc AGGTCAAACAGGAAGACAGACGTA TCACACCCAAGAACAAGCACA
Gapdh TGAAGCAGGCATCTGAGGG CGAAGGTGGAAGAGTGGGAG
H. suis AAAACAMAGGCGATCGCCCTGTA TTTCTTCGCCAGGTTCAAAGCG
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ND-1000, Fisher Scientifics). cDNA was synthesized using a cDNA
Synthesis Kit (Bio-Rad). RT-qPCR for analysis of the stomach and
duodenum samples was performed on a CFX384TM RT-qPCR System
with a C1000 Thermal Cycler (Bio-Rad, Hercules), using the 2xSen-
simix (Sybr No-Rox kit; Bioline), while for brain samples the RT-
qPCR was performed on the Light Cycler 480 system (Roche) using
the 2xSensimix (Sybr No-Rox kit; Bioline). Expression levels were
normalized to the expression of 3 reference genes: Hprt, H2afz
and Ppia for stomach and duodenum samples, Hprt, Rpl and Ubc
for choroid plexus samples and Gapdh, Rpl and Ubc for hippocam-
pus samples. The primer sequences are shown in Table 1.
2.7. Cytokine/chemokine measurements
The snap frozen gastrointestinal samples were lysed using lysis
buffer containing 0.5% CHAPS (Sigma-Aldrich) and a protease inhi-
bitor complete tablet (Roche Applied Science; 11 873 580 001).
Protein concentration of the samples was measured using the
Pierce BCA protein assay kit (Thermofisher Scientific). Cytokines
and chemokines in serum, CSF and protein lysates were measured
using the Bio-Plex cytokine assays (Bio-Rad) according to the man-
ufacturer’s instructions.
2.8. TLR4 activation analysis
Serum levels of TLR4 in serum were measured using the HEK-
Blue mTLR4 assay (InvivoGen) according to the manufacturer’s
instructions. HEK-Blue mTLR4 cells in detection medium were
seeded at 25.000 cells per well in a 96-well plate. After 18 h incu-
bation at 37 C with 10 times diluted serum derived from control
or H. suis infected mice, absorption of the culture medium was
measured at 655 nm with a absorbance plate reader (iMark Micro-
plate Absorbance Reader, Bio-Rad) and relative TLR4 activation
was calculated.
2.9. Quantification of the gastrointestinal permeability
Gastrointestinal permeability was determined as previously
described (Van Hauwermeiren et al., 2015; Vandenbroucke et al.,
2014). Briefly, 4 kDa FITC-dextran (Sigma) was intragastricallyadministered five hours before collection of blood. Blood was col-
lected in EDTA tubes (Sarstedt) by means of heart punction fol-
lowed by centrifugation. Subsequently, plasma was isolated and
diluted twice in sterile D-PBS. Gastrointestinal leakage was deter-
mined by measurement of fluorescence at kex/kem = 485/520 nm.
2.10. Quantification of blood-CSF barrier and BBB permeability
Blood-CSF barrier and BBB permeability were determined as
previously described (Brkic et al., 2015; Vandenbroucke et al.,
2012). Briefly, 4 kDa FITC-dextran (Sigma) was injected iv 1 h
before CSF collection. CSF was obtained from the fourth ventricle
using the cisterna magna puncture method (Balusu et al., 2016b;
Brkic et al., 2015; Vandenbroucke et al., 2012). Subsequently, mice
were perfused with D-PBS/heparin (0.2% heparin) and brain tissue
was isolated. CSF samples were diluted 100-fold in sterile D-PBS,
and blood-CSF barrier leakage was determined by measurement
of fluorescence at kex/kem = 485/520 nm. Brain samples were cut
into small pieces, incubated overnight at 37 C in formamide while
shaking and supernatant was collected after centrifugation for 15
min at maximum speed. Brain fluid was diluted 2-fold in sterile D-
PBS, and BBB leakage was determined by measurement of fluores-
cence at kex/kem = 485/520 nm.
2.11. Histopathology and immunohistochemistry
In order to evaluate inflammation in the stomach and duode-
num, paraffin sections of 5 mm were cut using a microtome
(Microm, Prosan, Thermo-Fisher). Sections were stained with
Hematoxylin Gill III Prosan (Merck) and Eosine Yellow (VWR)
according to standardized protocols. The H&E stainings of the
stomach were applied to determine the grade of overall gastritis,
using the modified visual analog scale similar to the adapted
Updated Sydney System as previously described (Flahou et al.,
2010). Gastric tissue was visualized using a light microscope (Leica
DM2000).
For zonula occludens 1 (ZO1) immunostaining of the stomach
and brain, 30 mm cryosections and 20 mm cryosections respectively
were cut using a cryostat (Micron HM500) and mounted on slides.
After air drying for 1 h, sections were fixated with 1% PFA for 10
min for the stomach, while for the brain antigen retrieval was
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min in PBS, sections were permeabilized for 10 min with 0.1% NP-
40. After two rinses with PBS, samples were blocked for 1 h at
room temperature with 5% goat serum and then incubated with
1/500 diluted anti-ZO1 primary antibody (Invitrogen; 617300).
After incubation overnight at 4 C, they were washed with PBS-T
(PBS supplemented with 0.1% Tween20) and 1/300 diluted goat
anti-rabbit DyLight633 secondary antibody (Thermo Scientific;
35562) diluted in 5% goat serum for 90 min at room temperature.
Finally, a Hoechst staining was performed to counterstain the
nuclei, the slides were dehydrated and xylene-based mounting
media was applied. Cells were visualized using a confocal micro-
scope (Leica TCS SP5 II).
For the MUC13 staining of the stomach sections of 5 mm were
cut from paraffin embedded tissue, using a microtome (Microm,
Prosan, Thermo-Fisher), and placed on a microscope slide. Deparaf-
finization was performed by the addition of successively, xylene
for 10 min, isopropyl alcohol for 5 min, 95% ethanol for 5 min,
50% ethanol for 5 min and aqua destillata for 5 min. Antigen retrie-
val was performed in citrate buffer (10 mM, pH6) using a pressure
cooker, where after samples were rinsed with washing buffer
(Dako). Slides were blocked for 5 min with peroxidase blocking
reagent (Dako) and rinsed with aqua destillata and washing buffer
(Dako). Successively slides were incubated for 30 min with the pri-
mary in-house polyclonal mouse MUC13 antibody, diluted in anti-
body diluent (1/1000, Dako, S3022). After a rinse step with
washing buffer (Dako), samples were incubated with labelled
polymer-HRP anti-mouse for 30 min at room temperature (Envi
sion + system-HRP (DAB); K4007). Samples were rinsed 2 times
with washing buffer (Dako), where after DAB + substrate (Dako)
and DAB + chromogen (Dako) were added during 5 min. Finally, a
counterstaining with haematoxylin was performed during 10
min, followed by a rinse step of 1 min using running tap water
and a dehydration step. Gastric tissue was visualized using a light
microscope (Leica DM2000).
For Helicobacter staining of the brain, 5 mm sections were cut
from paraffin embedded tissue and placed on a microscope slide.
After deparaffinization and hydration, antigen retrieval was per-
formed in citrate buffer (10 mM, pH6) using a pressure cooker.
Slides were incubated with H2O2 (Agilent; K4011). Successively,
slides were rinsed and incubated for 30 min with a polyclonal rab-
bit anti-Helicobacter antibody (1/320) (Agilent; B0471). After rins-
ing, slides were incubated with Envision Link Rabbit (Agilent;
K4011) and visualization was done using DAB chromogen (Agilent;
K4011). Finally, a counterstaining with haematoxylin was per-
formed and slides were dehydrated. Brain tissue was visualizes
using Olympus BX51 microscope.
For IBA1 immunostaining, paraffin sections of the brains were
processed as described before using the anti-IBA1 antibody (Wako;
019-19741) (Brkic et al., 2015). Imaging of whole brain sections
was done using Zeiss Axio Scan.Z1 followed by quantification using
Fiji (http://fiji.sc/Fiji). Quantification of the percentage of brown
colour was done via colour thresholding, with correction for the
total tissue surface, while the number of microglia/mm2 were
counted using the ZEN software.
For Claudin 1 (CLDN1) and GFAP immunostaining, paraffin-
embedded brains and stomach were sectioned at 5 mm, dewaxed,
and rinsed in water and PBS before staining. Antigen retrieval was
done using citrate buffer (Dako; S2031), followed by washing in
PBS. For CLDN1 staining, peroxidase was blocked by incubating
the slides in 3% H2O2 in methanol for 10 min, followed by washing
in PBS. Samples for CLDN1 and GFAP were blocked with 5% goat
serum in antibody diluent (Dako; S2022) for 30 min at RT. This
was followed by incubation overnight at 4 C with primary anti-
body (CLDN1, Invitrogen, 51-9000, 1/100; GFAP, DAKO, Z0334,
1/10000). The next day, slides were washed with PBS. For CLDN1immunostaining, slides were incubated with secondary antibody
coupled to HRP (Dako; E-K4003), and washed with PBS. An ampli-
fication step was performed using tyramide (TSA kit, Perkin Elmer)
and visualizationwas done using ABC (Vector) and DAB. Slideswere
counterstained with haematoxylin, dehydrated and xylene-based
mounting media was applied. Cells were visualized using Olympus
BX51 microscope. For GFAP, slides were incubated with 1/300
diluted goat anti-rabbit-DyLight633 secondary antibody (Thermo
Scientific; 35562) diluted in 5% normal goat serum for 90 min at
room temperature. Finally, a Hoechst staining was performed to
counterstain the nuclei, the slides were dehydrated and xylene-
based mounting media was applied. GFAP staining was visualized
using Zeiss Axio Scan.Z1 followed by quantification using QuPath.
Quantification of the percentage of positive red signal was done
via colour thresholding, with correction for the total tissue surface.
Representative images were taken using Leica TCS SP5 II.
2.12. Western blot
For CLDN1 and OCLN western blot analysis, choroid plexus tis-
sue from two mice was pooled and homogenized in 50 ml lysis buf-
fer containing 0.5% CHAPS and protease inhibitor complete tablet
(Roche Applied Science; 11 873 580 001). Protein concentration
was determined using the Thermo ScientificTM PierceTM Micro BCATM
Protein assay, and 80 mg of protein was loaded on a 15% SDS-PAGE
gel. Wet blotting was performed overnight at constant current (90
mA) at 4 C and the nitrocellulose membrane was blocked for 1 h
using Odyssey blocking buffer (Li-Cor; 927-40000), followed by
overnight incubation with 1/500 diluted anti-CLDN1 primary anti-
body at 4 C (Invitrogen; 35-2500). Next, the membrane was incu-
bated with 1/10000 diluted anti-rabbit Dylight800 secondary
antibody (Thermo Scientific; 35571) for 2 h on room temperature.
To correct for loading differences, membranes were incubated with
1/10000 diluted primary anti-actin antibody (MP; 691002) over-
night at 4 C, followed by incubation with anti-1/10000 diluted
mouse Dylight680 secondary antibody (Thermo Scientific; 35518)
for 1 h at room temperature. Next, the same blot was used to
detect OCLN by incubation with 1/1000 diluted primary anti-
occludin antibody (Life Technologies Europe B.V; 33-1500) over-
night at 4 C, followed by for 2 h incubation on room temperature
with 1/100000 diluted secondary antibody (Thermo Scientific;
35521). Visualisation of the bands was done using Odyssey soft-
ware and analysis was done in ImageStudio.
2.13. Behavioural tests
The cognitive behaviour of the mice was investigated using the
basic protocol for the open field and novel object recognition test,
as previously described (Antunes and Biala, 2012). Briefly, mice
were brought into the testing room 30 min before the experiment
to familiarize with the environment. To preclude the existence of
olfactory cues, all objects were thoroughly cleaned with 20% etha-
nol after each trial. On the habituation day (day 0), mice were
placed in a clear, plexiglass box (40 cm  40 cm  40 cm) and
allowed to explore the arena without objects for 5 min. Beha-
vioural analysis included velocity (cm/s), total distance travelled
(m) and time spend in the center or borders of the arena. The next
day, mice were subjected to the NOR test which includes 2 phases:
the training and the testing phase. During the training trial, 2 iden-
tical objects were placed at 2 opposite positions within the box at
the same distance from the nearest corner. Mice were allowed to
explore the identical objects for 5 min and were then returned to
their home cage. 15 min later, the mice were placed back in the
same box, where 1 of the 2 familiar objects was switched to a novel
one, and the 5 min testing phase was started. The time spent
exploring each of the objects was defined as occurring when the
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videotaped and scored manually. The percentage preference for
the novel object was calculated using the following formula: per-
centage novel object preference = (novel object exploration time/
(novel object exploration time + familiar object exploration tim
e)) * 100%. The NOR test is based on the spontaneous behaviour
of mice to interact more with a novel object than with a familiar
one. If the mouse explores the novel object for a longer time period,
this indicates memory for the familiar object. If the mouse explores
the novel and familiar objects for the same amount of time, this
indicates a lack or loss of memory for the familiar object presented
during the initial trial.
For the rotarod test (UB 47600), the drum of the rotarod (UB
47600) was slowly accelerated from a speed of 4–40 rpm over 300
s. The latency to fall off the rotarod within this period was recorded.
Mice received 5 consecutive trials without a training phase and the
mean latency to fall off the rotarod was used for analysis.
2.14. Statistics
Data were analysed by Mann-Whitney test using GraphPad
Prism or SPSS and are presented as means ± standard error of mean
(SEM), unless stated otherwise. Significance levels are indicated on
the graphs *, .01  P < .05; **, .001  P < .01; ***, .0001  P < .001;
⁄⁄⁄⁄, P < .0001.
3. Results
3.1. Colonization by H. suis induces gastric inflammation
One month after infection, colonization by H. suis was con-
firmed by analysing the stomach and small intestine. The mouse
stomach consists of a non-glandular part and a glandular part. In
this study, we analysed only the glandular part, consisting mainly
of the corpus and the antrum of the stomach. As shown in Fig. 1a,
the corpus and antrum of the stomach of H. suis-infected animals
were colonized by an average of 4.51E+05 and 7.30E+05 bacteria
per mg tissue, respectively. In contrast, no H. suis DNA was
detected in the stomach of control mice (Fig. 1a). Additionally, H.
suis DNA was also detected in the duodenum of infected mice
but to a lower extent than in the stomach (Fig. 1a).
Analysis of H&E-stained stomach of control animals showed no
or negligible infiltration of mononuclear and polymorphonuclear
cells in the mucosa and the submucosa, which agrees with the
normal histological image of the stomach (Fig. 1b). In contrast,
pronounced infiltration of mononuclear and polymorphonuclear
cells was detected in the stomach of H. suis-infected animals
(Fig. 1c), indicating gastric inflammation as scored by the Updated
Sydney System (Fig. 1d). Furthermore, inflammation was also asso-
ciated with changes in the expression levels of pro-inflammatory
cytokines and chemokines. C57BL/6 mice have a typical Th17
response in the stomach when infected with H. suis (Flahou et al.,
2012). Based on previous results in the research group, we
therefore focused on some typical Th17 related genes: Il1b, IL8
homologs (Lix and Kc), Il6, Il10, Il17 and Tnf. Gene expression
analyses revealed that the mRNA levels of the murine interleukin
8 (IL8) homolog keratinocyte chemoattractant (Kc) and
lipopolysaccharide-induced CXC chemokine (Lix) were signifi-
cantly up-regulated in corpus (Fig. 1e) and in antrum (Fig. 1f) of
H. suis-infected mice. A significant increase in gene expression of
Il1b was observed only in the corpus of those animals (Fig. 1e)
and a significant decrease of Il10 in the antrum (Fig. 1f). Il6 and
Tnf were not detected in stomach and duodenum. Additionally, a
significant increase in protein levels of IL1b and IL17 was observed
in the corpus of the stomach of H. suis-infected mice (Fig. 1h-i). In
contrast, no significant changes in the expression of cytokines andchemokines were found in the duodenum of mice infected with H.
suis (Fig. 1g).
3.2. Gastric H. suis infection induces inflammation and activation of
microglia in the brain
To determine whether H. suis affects the brain, cerebrospinal
fluid (CSF) and brain tissue were analysed for inflammation. Bio-
plex analysis of CSF revealed no significant changes in cytokine
and chemokine levels of IL1b, KC, IL6 and IL10 (Fig. 2a), IL17 and
TNF levels were not above the detection level. However, a signifi-
cantly higher concentration of soluble tumour necrosis factor
receptor 1 (sTNFR1) was found in the CSF of H. suis-infected mice
(Fig. 2b). Despite the limited changes in the CSF, a significantly
stronger expression of Il6 was detected in the brain hippocampus,
while Il1b, Tnf and Kc expression was unaffected (Fig. 2c). Lix, Il10
and Il17 were not detected in the hippocampus. Since microglia
are important mediators of brain inflammation, we stained brain
sections for ionized calcium binding adaptor molecule 1 (IBA1), a
marker for microglia (Fig. 2d-e). Automatic analysis showed a sig-
nificant increase in the total IBA1-positive signal in the brain
(Fig. 2f). Quantification of the number of microglia/mm2 at the sub-
ventricular showed an increasing trend (Fig. 2g). These data indi-
cate that H. suis activates a pro-inflammatory response in the
brain. In parallel, we also analysed whether astrocytes were
affected. Therefore, we performed an immunostaining to visualize
astrocytes using anti-glial fibrillary acidic protein (GFAP), followed
by confocal imaging (Fig. 2h-i) and automated analysis (Fig. 2j), but
no significant difference could be observed.
Next, we determined whether H. suis infection influences cogni-
tion. Therefore, mice were subjected to the novel object recogni-
tion (NOR), open field and rotarod test. As shown in Fig. 2k, H.
suis infection results in loss of short-term memory in mice, reveal-
ing that the mild brain inflammation caused by H. suis infection
negatively affects cognition. As shown in Fig. 2, H. suis-infected ani-
mals move with a higher velocity (Fig. 2l) and over a greater dis-
tance (Fig. 2m), compared to control mice. In contrast, no
difference in the time spend in the center of the arena was
observed (Fig. 2n). This suggests that H. suis infection doesn’t affect
anxiety, but does have an effect on activity. In agreement with the
open field test, the rotarod test revealed that H. suis-infected mice
are more active compared to control mice, reflected by a higher
latency to fall (Fig. 2o).
3.3. H. suis infection induces loss of the blood-CSF barrier but does not
affect BBB integrity
The presence of tight brain barriers, including the BBB and the
blood-CSF barrier, ensure brain homeostasis (De Bock et al., 2014),
but several inflammatory triggers are known to disrupt barrier
integrity (Alvarez-Arellano and Maldonado-Bernal, 2014; Brkic
et al., 2015; Gorle et al., 2016; Nielsen et al., 2012;
Vandenbroucke et al., 2012). Here, we studied whether the effect
of H. suis on the brain is associated with loss of barrier integrity.
No change in BBB permeability was observed (Fig. 3a). In contrast
to the BBB, a significant increase in blood-CSF barrier permeability
was seen after one month of infection (Fig. 3b). Gene expression
analysis of the blood-CSF barrier located at the choroid plexus
revealed that several tight-junction genes were affected by H. suis
infection. As shown in Fig. 3c, gene expression of claudin 1 (Cldn1)
and occludin (Ocln) was significantly down-regulated in the pres-
ence of H. suis infection. Other tight-junction genes, such as Cldn5,
zona occludens 1 (Zo1) and Zo3 decreased, but not significantly so.
Next, immunostaining was performed to determine the subcellular
localization of CLDN1 and ZO1. The arrowheads in Fig. 3d-g point to
the loss of apical localization of CLDN1 and ZO1 in the choroid
Fig. 1. Analysis of colonization and inflammation in the stomach and duodenum after one month of Helicobacter suis (H. suis) infection. (a) H. suis colonization in the stomach
(corpus and antrum) and duodenum of C57BL/6 mice one month after H. suis infection compared to control mice (n = 7–10). (b-c) Representative H&E images of stomach
sections of control (b) and H. suis-infected (c) C57BL/6 mice one month after infection. (d) Inflammation score based on H&E staining of stomach of H. suis-infected and control
mice (n = 5). (e-g) Inflammatory gene expression analysis (represented as fold change) of interleukin 1b (Il1b), lipopolysaccharide-induced CXC chemokine (Lix), keratinocyte
chemoattractant (Kc), Il10 and Il17 in corpus (e) and antrum (f) of stomach and duodenum (g) in C57BL/6 mice after one month of infection with H. suis compared to control
mice. Data were analysed by Student’s T-test (n = 3–10). (h-i) Levels of IL1b (h) and IL17A (i) in protein lysates determined using Bioplex of stomach (corpus and antrum) and
duodenum after inoculation with H. suis or growth medium. Data were analysed by Student’s t-test (n = 5).
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that H. suis infection compromises the functionality of the blood-
CSF barrier but does not affect the integrity of the BBB. Finally, west-
ern blot analysis was performed to determine the levels of CLDN1
and OCLN in the choroid plexus. As shown in Fig. 3h-k, the levels
of both CLDN1 (Fig. 3h and j) and OCLN (Fig. 3i and k) are signifi-
cantly lower after 1 month of H. suis infection.
3.4. H. suis infection induces loss of gastric mucosal barrier integrity
and subsequent systemic inflammation
Increased gastrointestinal permeability, which could lead to
leakage of pro-inflammatory mediators and bacterial metabolitesfrom the gut into the systemic circulation, is considered one of
the gut-brain axis pathways (Cryan and Dinan, 2012; Mayer
et al., 2014). In our study, we used oral gavage of FITC-dextran to
investigate the influence of gastric H. suis infection on the gastroin-
testinal barrier. Plasma fluorescence analysis revealed a significant
increase in gastrointestinal permeability after one month of H. suis
infection (Fig. 4a). The gastric mucosal barrier is composed of the
gastric mucosa (epithelium, lamina propria and muscularis
mucosa), with a mucus layer on top (Caron et al., 2015;
Kawakubo et al., 2004; Kufe, 2009; Linden et al., 2002; McGuckin
et al., 2011; Yamashiro, 2006). This gastric mucus layer, consisting
mainly of secreted mucins, is the first barrier pathogens encounter.
The membrane-associated mucins located underneath this mucus
Fig. 2. Analysis of brain inflammation in response to one month Helicobacter suis (H. suis) infection. (a) Levels of interleukin 1b (IL1b), keratinocyte chemoattractant (KC), IL6
and IL10 in cerebrospinal fluid (CSF) determined using Bioplex. Data were analysed by Student’s T-test (n = 4–5). (b) Concentration of sTNFR1 in the cerebrospinal fluid (CSF)
of control mice and mice infected with H. suis (n = 10). (c) Expression of inflammatory genes Il1b, Kc, Il6 and Tnf in the hippocampus of C57BL/6 mice infected with H. suis
compared to control mice, represented as fold change. Data were analysed by Student’s T-test (n = 3–5). (d-e) Representative images of ionized calcium-binding adapter
molecule 1 (IBA1) staining of brain sections at the subventricular zone from C57BL/6 mice of control mice (d) and of mice after one month infection with H. suis (e) (n = 5). (f)
Quantification of the percentage brown staining (IBA1) in the whole brain of H. suis-infected and negative control mice (n = 5). (g) Quantification of the amount of microglia at
the subventricular zone of control and H. suis-infected mice (n = 5). (h-i) Representative images of glial fibrillary acidic protein (GFAP) staining on brain sections at the
subventricular zone from control mice (h) and of mice after one month infection with H. suis (i) (n = 4–5). (j) Quantification of the percentage red staining (GFAP) at the
subventricular zone of H. suis-infected and negative control mice (n = 5). (k) Preference for the new object, determined by the novel object recognition (NOR) test, in control
and H. suis-infected mice during training (black) and testing (grey). A Wilcoxon test was used to analyse the comparison of training and testing (n = 15). (l-o) Open field test of
control and mice infected with H. suis. The velocity (l), total distance (m) and % time in center of arena (n) was measured (n = 13–16). (o) Average time spent on an
accelerating rotarod of control and mice infected with H. suis (n = 14–15).
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cell surface (McGuckin et al., 2011). Changes in mucin distribution
and expression might affect the integrity of the gastric mucosalbarrier (Kufe, 2009). Therefore, we analysed gastric mucin expres-
sion. RT-qPCR analysis revealed a significantly increased gene
expression of the transmembrane mucin 13 (Muc13) in the corpus
Fig. 3. Brain barrier analysis in response to one month of Helicobacter suis (H. suis) infection. (a) Relative blood-brain barrier (BBB) permeability one month after inoculation
with growth medium or H. suis (n = 5). (b) Relative blood-cerebrospinal fluid (CSF) barrier permeability one month after inoculation with growth medium or H. suis (n = 8–
10). (c) Expression of the tight junction genes claudin 1 (Cldn1), Cldn5, occludin (Ocln), zonula occludens (Zo1) and Zo3 in choroid plexus tissue from C57BL/6 mice infected
with H. suis compared to control mice (n = 5). (d-e) Representative images of choroid plexus tissue stained for CLDN1 of control mice (d) and H. suis-infected mice (e) (n = 5).
(f-g) Representative images of immunostaining of ZO1 in the choroid plexus of control (f) and H. suis-infected (g) mice (n = 3–4). (h-k) Western blot analysis of CLDN1 (h) and
OCLN (i) in choroid plexus tissue from control and H. suis-infected mice. Quantification was done using ImageStudio using actin as the loading control for CLDN1 (j) and OCLN
(k) (n = 3). (Abbreviations: CLDN1, claudin-1; CP, choroid plexus; CSF, cerebrospinal fluid; OCLN, occludin).
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Muc6 were unaffected (Fig. 4b). This finding was confirmed histo-
logically (Fig. 4e-f): compared to control mice (Fig. 4e), apical
membrane and cytoplasmatic MUC13 staining (brown) was much
more pronounced in the mucus-secreting epithelial cells of the
stomach of H. suis-infected mice (Fig. 4f). In contrast, Muc13 geneexpression did not change in antrum and was significantly
down-regulated in the duodenum of H. suis-infected animals
(Fig. 4c-d).
The gastric epithelium located underneath the mucus layer is
formed by epithelial cells connected by tight junction proteins
(Caron et al., 2015). We performed immunostaining to determine
Fig. 4. Analysis of the gastrointestinal barrier after one month of Helicobacter suis (H. suis) infection. (a) The relative gastrointestinal permeability of control mice compared to
mice infected with H. suis (n = 5). (b) Expression of mucins Muc5ac, Muc5b, Muc13 and Muc6 in the corpus of the stomach of C57BL/6 mice inoculated with H. suis and of
control mice, represented as fold change (n = 7–10). (c-d) Expression of the mucinMuc13 in antrum of the stomach (c) and in duodenum (d) in C57BL/6 mice one month after
infection with Helicobacter suis (H. suis) compared to control mice, represented as fold change (n = 5–9). (e-f) Representative images of immunostaining of MUC13 in the
stomach of control mice (e) and H. suis infected mice (f) (n = 5). (g-h) Representative confocal images of zonula occludens 1 (ZO1) staining in the stomach of control mice (g)
and H. suis-infected C57BL/6 mice (h) (n = 4–5).
N. Gorlé et al. / Brain, Behavior, and Immunity 69 (2018) 35–47 43whether the H. suis-induced alterations in gastrointestinal barrier
integrity were correlated with changes in junctional proteins in
the stomach. Confocal imaging revealed that expression of ZO1
was disturbed. Compared to control mice, in which ZO1was located
mainly at the apical side of the stomach epithelial cells (Fig. 4g), the
ZO1 signal wasmuchmore diffuse in stomach samples fromH. suis-
infected animals (Fig. 4h). The changes in expression and localisa-
tion of both MUC13 and ZO1 might thus explain the increased gas-
trointestinal leakage in the presence of H. suis infection.
Disruption of the gastric mucosal barrier might result in leakage
of H. suis into the periphery and subsequent translocation into the
brain. However, neither RT-qPCR analysis on hippocampal tissue
and anti-Helicobacter immunostaining on brain sections could
show H. suis in the brain as displayed in Fig. 5a-f.
Alternatively, also pro-inflammatory cytokines, chemokines
and bacterial metabolites or fragments might leak from the
stomach into the blood, leading to systemic inflammation
(Clapp et al., 2017; Cryan and Dinan, 2012; Fung et al., 2017;Kelly et al., 2017; Tognini, 2017). Additionally, recent studies indi-
cated that alterations in circulating cytokine levels may directly
influence the functionality of the brain barriers and the brain
(Balusu et al., 2016b; Cryan and Dinan, 2012; Stridh et al., 2013;
Vandenbroucke et al., 2012; Varatharaj and Galea, 2016).
Therefore, the presence of systemic inflammation was evalu-
ated by analysing serum of control and H. suis-infected mice. As
shown in Fig. 5g, H. suis infection leads to a significant increase
in Toll-Like Receptor 4 (TLR4) ligands in the serum. Additionally,
as shown in Fig. 5h, the level of the pro-inflammatory cytokine
IL1b increased significantly in the serum of H. suis-infected mice,
while IL6 and TNF serum levels were below detection limit (data
not shown). These findings indicate that the loss of blood-CSF bar-
rier integrity observed in our study might have been caused by a
low grade, systemic inflammation induced by H. suis. In agreement
with this finding, gene expression analysis of choroid plexus tissue
revealed a significantly increased expression of pro-inflammatory
cytokine Il1b (Fig. 5i).
Fig. 5. Analysis of systemic and choroid plexus inflammation after one month of Helicobacter suis (H. suis) infection. (a) Analysis of the presence of H. suis determined by RT-
qPCR on corpus and hippocampus tissue derived from C57BL/6 mice one month after H. suis infection compared and control mice (n = 6–10). (b-f) Representative images of
the stomach (b; positive control), choroid plexus (c-d) and hippocampus (e-f) stained for Helicobacter in sections from control and H. suis-infected mice. (Abbreviations: CP:
choroid plexus; CSF: cerebrospinal fluid) (g) Analysis of relative TLR4 ligand levels in serum of C57BL/6 mice one month after H. suis infection compared to control mice (n =
10) determined using HEK-Blue mTLR4 reporter cells (InvivoGen). (h) Levels of serum interleukin (IL) 1b, keratinocyte chemoattractant (KC), IL10 and IL17 determined using
Bioplex after inoculation of mice with H. suis or growth medium. Data were analysed by Student’s t-test (n = 3–4). (i) Expression of the inflammatory genes Il1b, Kc, Il6 and Tnf
in choroid plexus tissue of C57BL/6 mice inoculated with H. suis or growth medium, represented as fold change (n = 3–5).
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Alterations in the gut microbiome are believed to contribute to
many different human health problems (Bercik et al., 2011;
Boulange et al., 2016; Bravo et al., 2011; Clapp et al., 2017;
Clemente et al., 2012; Dinan and Cryan, 2017b; Fung et al., 2017;
Kelly et al., 2017; Ochoa-Reparaz and Kasper, 2014; Parracho
et al., 2005; Tognini, 2017; Walters et al., 2014; Zhang et al.,
2015). Next to the direct effects H. pylori infection on the gastroin-
testinal system (Camilo et al., 2017; Johnson and Ottemann, 2017;
Kusters et al., 2006; Li et al., 2016; Mayer et al., 2014; Pere-
Vedrenne et al., 2017; Teng et al., 2017), it has been associated
with the occurrence of different neurodegenerative disorders,
including Alzheimer’s disease (Alvarez-Arellano and Maldonado-
Bernal, 2014; Doulberis et al., 2017; Roubaud Baudron et al.,
2016; Wirdefeldt et al., 2011; Wong et al., 2014) and Parkinson’s
disease (Alvarez-Arellano and Maldonado-Bernal, 2014; Blaecher
et al., 2013; Dinan and Cryan, 2017a; Mridula et al., 2017; Mulak
and Bonaz, 2015; Wirdefeldt et al., 2011; Wong et al., 2014). We
recently highlighted a similar association of gastric H. suis infec-
tions in Parkinson’s disease (Blaecher et al., 2013). However, it
remains unknown how gastric Helicobacter infection in general
influences the brain.
The gastrointestinal system and the brain are connected
through neural, endocrine and immune pathways (Dinan and
Cryan, 2017b). Here, we observed that one month of infection with
H. suis resulted in increased brain inflammation. In particular, we
observed a moderate but significant up-regulation of Il6 gene
expression in the hippocampus, elevated levels of sTNFR1 in CSF(a biomarker for Alzheimer’s disease (Jiang et al., 2011)), and more
microglial IBA1 positivity in the brain. Interestingly, elevated brain
levels of IL6 have also been reported in traumatic brain injury
(Goodman et al., 1990; Kossmann et al., 1995), depression
(Brietzke et al., 2009), Parkinson’s disease (Boka et al., 1994) and
Alzheimer’s disease (Angelopoulos et al., 2008), suggesting a role
for IL6 in the above-mentioned neuropathologies. Furthermore,
microglia activation has been observed in H. pylori infection (Lo
et al., 2009), and priming of microglia by prior pathology has
shown to accelerate brain pathology (Cunningham, 2013). Strik-
ingly, we observed that the limited H. suis-induced increase in
brain inflammation is associated with a decrease in cognitive
decline, as determined via the NOR test. Additionally, higher activ-
ity was observed in both the open field and rotarod test, which has
been linked to Parkinson’s disease before, namely in the A53T
model of Parkinson’s disease (Paumier et al., 2013). While no data
are available on H. suis, it has been shown that the cognitive state
of H. pylori positive mild cognitive impairment (MCI) patients cor-
related with serum anti-H. pylori IgG concentration, suggesting
that infection might partially contribute to the pathophysiology
of MCI (Kountouras et al., 2007).
As mentioned, neural, endocrine and immune pathways con-
nect the gut and the brain. However, a series of barriers, including
the BBB and the blood-CSF barrier (De Bock et al., 2014) prevent
direct contact between blood and brain and assure brain home-
ostasis. Our results indicate that gastric H. suis infection induces
leakage of the blood-CSF barrier but not of the BBB. One month
after H. suis infection, we observed increased leakiness of the
blood-CSF barrier, which will subsequently affect CSF and brain
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grade brain inflammation might be below the threshold to induce
loss of BBB integrity. Additionally, we can’t exclude that the
method used is not sensitive enough to detect BBB leakage. The
blood-CSF barrier has a lower transepithelial electrical resistance
compared to the BBB (Gorle et al., 2016), making it more sensitive
to inflammatory triggers (both from the periphery and the brain).
Of note, the blood-CSF barrier is also more dynamic and is seen
as an immune sensor for the central nervous system (Shechter
et al., 2013; Strazielle and Ghersi-Egea, 2000). The disturbance of
the blood-CSF barrier was accompanied by loss of tight junctions,
and specifically by a significant decrease in expression of Cldn1,
Ocln and disturbed localization of CLDN1 and ZO1 protein in the
choroid plexus epithelium. The choroid plexus epithelium is
uniquely positioned between blood and brain, and we and others
believe that this blood-CSF interface is an essential player in the
communication between the periphery and the brain. Indeed, sev-
eral studies reported that choroid plexus epithelial cells sense
inflammatory changes in the periphery, which in turn induces
changes in functionality of the choroid plexus epithelial cells
(Balusu et al., 2016b; Marques et al., 2009, 2007; Thouvenot
et al., 2006; Vandenbroucke et al., 2012). The response of the chor-
oid plexus can vary depending on the nature and duration of the
stimuli. A single, acute injection of LPS, leads to rapid changes in
the transcriptome of the choroid plexus, with a large number of
genes which are massively upregulated. A more attenuated
response is seen when the stimulus is repeated (Marques and
Sousa, 2015). This is also observed in models of multiple sclerosis
and patients with major depressive disorders. Expression of pro-
inflammatory mediators, such as LPS, IL1, TNFa and IFNc, can
cause breakdown of the blood-CSF barrier, but can also induce
the expression of trafficking molecules in the choroid plexus
(Kunis et al., 2013; Schwerk et al., 2010; Steffen et al., 1996; Zeni
et al., 2007). This leads to infiltration of T cells and macrophages,
which supports central nervous system repair (Kunis et al.,
2013). In a model of spinal cord injury, the choroid plexus is impor-
tant in the recovery, by recruiting anti-inflammatory M2 macro-
phages and CD4+ T cells to the injury (Shechter et al., 2013).
However, immune trafficking is not always beneficial. For example,
viral infection can spread to the brain via the upregulation of
immune cell trafficking at the choroid plexus (Meeker et al., 2012).
In agreement with these studies, we observed H. suis-induced
systemic inflammation, characterized by increased levels of TLR4
ligands and IL1b in the serum, and this resulted in increased
inflammation at the choroid plexus, loss of blood-CSF barrier integ-
rity and subsequently brain inflammation.
The observed H. suis-induced changes in the choroid plexus are
small but significant, which is in line with the literature. Indeed, it
has been shown that the response of the choroid plexus to an acute
peripheral stimulation is rapid, strong and transient, while its
response is weaker, but persistent in case of a continuous stimula-
tion (Marques and Sousa, 2015). H. suis-induced blood-CSF barrier
leakage and associated dysfunction of the choroid plexus epithe-
lium is known to be destructive to the brain (Balusu et al.,
2016a; Johanson et al., 2011; Marques et al., 2007; Redzic et al.,
2005). In agreement with this, increased blood-CSF barrier perme-
ability has been observed in several neuroinflammatory disorders,
including Alzheimer’s disease, aging and Parkinson’s disease
(Balusu et al., 2016a; Brkic et al., 2015; Gorle et al., 2016;
Marques et al., 2013; Pisani et al., 2012). Consequently, this sug-
gests that the H. suis-induced increased blood-CSF barrier leakage
contributes to the observed neuroinflammation and cognitive
decline and increased activity. Both the higher activity in the open
field test and the higher latency to fall in the rotarod test have been
linked to Parkinson’s disease before, namely in the A53T model of
Parkinson’s disease (Paumier et al., 2013).Disruption of the gastric mucosal barrier results in leakage of
inflammatory cytokines, chemokines and/or bacterial components
from the stomach into the systemic circulation (Cryan and Dinan,
2012; Mayer et al., 2014), thereby inducing systemic inflammation.
In our study, the extent of colonization of the stomach by H. suis
was similar to what has been reported (Flahou et al., 2010). DNA
from H. suis was also found in the duodenum, but it is not clear
whether this pathogen colonized the duodenum or, otherwise,
the qRT-PCR picked up DNA from bacteria colonizing the stomach.
H. suis infection evoked a pro-inflammatory immune response in
the stomach characterized by infiltration of innate immune cells
and up-regulation of IL1b and murine IL8 homologue genes Lix
and Kc; these observations are in line with previous studies
(Bosschem et al., 2017a, b; Flahou et al., 2012; Flahou et al.,
2010). Inflammation in the stomach was also accompanied by
increased gastrointestinal barrier permeability and changes in
the localization of the tight junction protein ZO1. Concordant with
our study, co-culture of primary human gastric epithelial cells with
H. pylori resulted in the disruption of membrane ZO1 (Wroblewski
and Peek, 2011).
Aberrant expression of transmembrane mucins has also been
shown to play a role in disturbance of mucosal barrier integrity
(Kufe, 2009). In our study, an inappropriate overexpression of the
membrane-associated mucin MUC13 was seen. This mucin, which
is predominantly expressed in the intestines and only at a very low
level in the stomach, seems to be induced by IL1b in the inflamed
stomach during Helicobacter infection (Cheng et al., 2016). Inappro-
priate overexpression of transmembrane mucins can affect gastric
mucosal barrier integrity by disrupting cell polarity and cell-cell
interactions (Kufe, 2009), but further investigations are necessary
to confirm the role of MUC13 in gastric mucosal barrier dysfunc-
tion. Taken together, gastric H. suis infection-induced inflammation
in the stomach, which was associated with gastric mucosal damage
resulting in leakage of inflammatory mediators into the blood and
leading to systemic inflammation.
In conclusion, we identified a pivotal role of the choroid plexus
in the communication between the gastrointestinal tract and the
brain. Our results indicate that H. suis induces alterations in the
brain, including inflammation and cognitive decline, via loss of
blood-CSF barrier integrity in response to H. suis-induced leakage
of the gastrointestinal barrier and subsequent systemic
inflammation.
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